Atul Dandekar, CSBO at Maze Therapeutics, Inc. (MAZE), sold 6,434 shares at $26.38 ($169K) on 2026-09-02, disclosed to the SEC on 2026-09-04.
Open-market sale of $169k MAZE by CSBO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.38 | 2,800 | $74K | 43.7% |
| 2 | $27.12 | 391 | $11K | 6.3% |
| 3 | $25.81 | 36 | $929 | 0.6% |
| 4 | $26.01 | 3,207 | $83K | 49.4% |
| Total | $26.24 avg | 6,434 | $169K | 100% |
| Filing → |
| MAZE | SELL | 2026-07-31 | $205K | — | Filing → |
| MAZE | SELL | 2026-07-01 | $210K | — | Filing → |
| MAZE | SELL | 2026-06-02 | $198K | — | Filing → |